U.S. markets open in 41 minutes
  • S&P Futures

    3,833.25
    -5.75 (-0.15%)
     
  • Dow Futures

    31,540.00
    +75.00 (+0.24%)
     
  • Nasdaq Futures

    12,562.00
    -101.75 (-0.80%)
     
  • Russell 2000 Futures

    2,201.00
    +11.30 (+0.52%)
     
  • Crude Oil

    66.05
    -0.04 (-0.06%)
     
  • Gold

    1,688.40
    -10.10 (-0.59%)
     
  • Silver

    25.18
    -0.11 (-0.42%)
     
  • EUR/USD

    1.1876
    -0.0048 (-0.40%)
     
  • 10-Yr Bond

    1.5980
    +0.0440 (+2.83%)
     
  • Vix

    26.21
    -2.36 (-8.26%)
     
  • GBP/USD

    1.3849
    +0.0021 (+0.15%)
     
  • USD/JPY

    108.6820
    +0.3000 (+0.28%)
     
  • BTC-USD

    50,883.96
    +199.82 (+0.39%)
     
  • CMC Crypto 200

    1,028.10
    +84.93 (+9.00%)
     
  • FTSE 100

    6,639.06
    +8.54 (+0.13%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Is Chemed Corporation's (NYSE:CHE) Latest Stock Performance A Reflection Of Its Financial Health?

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

Chemed (NYSE:CHE) has had a great run on the share market with its stock up by a significant 15% over the last month. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company’s key performance indicators to see if they could be influencing the market. Particularly, we will be paying attention to Chemed's ROE today.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

View our latest analysis for Chemed

How Do You Calculate Return On Equity?

The formula for ROE is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Chemed is:

34% = US$271m ÷ US$801m (Based on the trailing twelve months to September 2020).

The 'return' is the yearly profit. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.34 in profit.

What Is The Relationship Between ROE And Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.

Chemed's Earnings Growth And 34% ROE

First thing first, we like that Chemed has an impressive ROE. Secondly, even when compared to the industry average of 12% the company's ROE is quite impressive. As a result, Chemed's exceptional 23% net income growth seen over the past five years, doesn't come as a surprise.

We then compared Chemed's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 8.0% in the same period.

past-earnings-growth
past-earnings-growth

Earnings growth is a huge factor in stock valuation. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. Doing so will help them establish if the stock's future looks promising or ominous. If you're wondering about Chemed's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Chemed Using Its Retained Earnings Effectively?

Chemed has a really low three-year median payout ratio of 9.2%, meaning that it has the remaining 91% left over to reinvest into its business. So it looks like Chemed is reinvesting profits heavily to grow its business, which shows in its earnings growth.

Moreover, Chemed is determined to keep sharing its profits with shareholders which we infer from its long history of paying a dividend for at least ten years.

Summary

In total, we are pretty happy with Chemed's performance. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, according to the latest industry analyst forecasts, the company's earnings are expected to shrink in the future. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.